原发性和转移性肾细胞癌热消融与放疗消融的影像学考量
本文综述影像学在肾细胞癌消融治疗(经皮和立体定向热消融及放疗)中的作用,涵盖治疗前选择与规划、术中引导、并发症评估、术后短期和长期监测及治疗反应评估。数据显示消融疗效与肾切除术相当,且成本和并发症更低。消融后治疗反应和疾病复发模式可能与常规手术和化疗不同,尤其立体定向放疗。
要点
- 消融治疗前影像用于患者选择和规划,术中引导,术后监测并发症和疗效。
- 消融后治疗反应和复发模式不同于手术和化疗,尤其立体定向放疗后需注意。
- 消融疗效与肾切除术相当,且成本和并发症更低,但影像评估需熟悉特定模式。
临床应用与阅片要点
- 治疗前影像用于选择适合消融的患者并制定规划。
- 术中影像引导消融操作,术后评估并发症和监测疾病。
- 消融后治疗反应和复发模式可能与手术和化疗不同,尤其立体定向放疗后需注意鉴别。
局限性
- 为综述性文章,未提供原始研究数据或系统评价方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ablative (percutaneous and stereotactic) thermal and radiotherapy procedures for management of both primary and metastatic renal cell carcinoma are increasing in popularity in clinical practice. Data suggest comparable efficacy with lower cost and morbidity compared to nephrectomy. Ablative therapies may be used alone or in conjunction with surgery or chemotherapy for treatment of primary tumor and metastatic disease. Imaging plays a crucial role in pre-treatment selection and planning of ablation, intra-procedural guidance, evaluation for complications, short- and long-term post-procedural surveillance of disease, and treatment response. Treatment response and disease recurrence may differ considerably after ablation, particularly for stereotactic radiotherapy, when compared to conventional surgical and chemotherapies. This article reviews the current and emerging role of imaging for ablative therapy of renal cell carcinoma.
引用
- Haroon M, Sathiadoss P, Hibbert RM, et al. Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma. Abdom Radiol (NY). 2021. PMID: 34245341. doi:10.1007/s00261-021-03178-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。